Atara Biotherapeutics (ATRA) Change in Taxes (2013 - 2014)

Atara Biotherapeutics (ATRA) posted Change in Taxes of -$62000.0 for Q4 2014, up 32.61% on a QoQ basis from -$92000.0 in Q1 2014, and down 145.26% year-over-year from $137000.0 in Q4 2013.

Atara Biotherapeutics (ATRA) Change in Taxes (2013 - 2014) Analysis & Trends

Atara Biotherapeutics' Change in Taxes history runs 2 years deep, the most recent figure standing at -$62000.0 for Q4 2014.

  • Quarterly Change in Taxes fell 145.26% year-over-year to -$62000.0 in Q4 2014, while the trailing twelve-month figure through Dec 2014 was -$154000.0 (changed N/A YoY) and the FY2014 annual result came in at -$154000.0, down 204.05% from the prior year.
  • Change in Taxes was -$62000.0 for Q4 2014 at Atara Biotherapeutics, up from -$92000.0 in the prior quarter.
  • Across five years, Change in Taxes topped out at $137000.0 in Q4 2013 and bottomed at -$92000.0 in Q1 2014.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Taxes (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -8,939.03
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - -
10 Atara Biotherapeutics 110.04 Mn 101.68 Mn 392,000.00 -

Historic Data

Download Data
DateValue
Dec 31, 2014 -62,000.00
Dec 31, 2014 -62,000.00
Mar 31, 2014 -92,000.00
Mar 31, 2014 -92,000.00
Dec 31, 2013 137,000.00
Dec 31, 2013 137,000.00